Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Hysterectomy, hysteroscopy & ablation · Massachusetts | Hysterectomy, hysteroscopy & ablation · New York | |
|---|---|---|
| Surgeons, 2024 | 41 | 75 |
| Medicare fee-for-service cases | 3,182 | 6,108 |
| Growth since 2019 (Medicare FFS) | −0.5%/yr | −0.3%/yr |
| Forecast cases (Medicare FFS) | 3,720 in 2030 | 6,960 in 2030 |
| Forecast growth | +2.6%/yr to 2030 | +2.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.6 | 3.7 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 17% (−0 pts since 2019) | 30% (+6 pts since 2019) |
| Cases per surgeon | 78 | 81 |
| Top 10 surgeons' share | 44% | 26% |
| Surgeons growing | 4 | 4 |
| New since the base year | 6 | 8 |
| Likely to stop billing it | 13 by 2026 | 32 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $99 | $874 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.